BACKGROUND: A brief, self-administered measurement of pain frequency, intensity, and burden is desirable in both research and clinical settings. We describe the development and initial psychometric properties of a new instrument, the Pain Frequency, Intensity, and Burden Scale (P-FIBS). METHODS: The P-FIBS was administered to all participants (N = 302) with psychostimulant use disorders in the National Institute on Drug Abuse Clinical Trials Network's STRIDE (Stimulant Reduction Intervention using Dose Exercise) multisite trial. RESULTS: The four items on the P-FIBS demonstrate high item-total correlations (range 0.70-0.85) with a high Cronbach's alpha (0.90). The P-FIBS demonstrated a strong negative correlation with the bodily pain sub-score of the Short Form Health Survey (r = -0.76, p < 0.0001) and did not correlate with a measure of cocaine (r = 0.09, p = 0.12) or methamphetamine (r = -0.06, p = 0.33) craving. CONCLUSIONS: The P-FIBS demonstrates good psychometric properties. This brief measure can be used to assess pain in research settings or as a screen in clinical settings. Further research is needed to assess the measure's sensitivity to change with treatment.
BACKGROUND: A brief, self-administered measurement of pain frequency, intensity, and burden is desirable in both research and clinical settings. We describe the development and initial psychometric properties of a new instrument, the Pain Frequency, Intensity, and Burden Scale (P-FIBS). METHODS: The P-FIBS was administered to all participants (N = 302) with psychostimulant use disorders in the National Institute on Drug Abuse Clinical Trials Network's STRIDE (Stimulant Reduction Intervention using Dose Exercise) multisite trial. RESULTS: The four items on the P-FIBS demonstrate high item-total correlations (range 0.70-0.85) with a high Cronbach's alpha (0.90). The P-FIBS demonstrated a strong negative correlation with the bodily pain sub-score of the Short Form Health Survey (r = -0.76, p < 0.0001) and did not correlate with a measure of cocaine (r = 0.09, p = 0.12) or methamphetamine (r = -0.06, p = 0.33) craving. CONCLUSIONS: The P-FIBS demonstrates good psychometric properties. This brief measure can be used to assess pain in research settings or as a screen in clinical settings. Further research is needed to assess the measure's sensitivity to change with treatment.
Authors: Stephen K Brannan; Craig H Mallinckrodt; Eileen B Brown; Madelaine M Wohlreich; John G Watkin; Alan F Schatzberg Journal: J Psychiatr Res Date: 2005-01 Impact factor: 4.791
Authors: Dagmar Amtmann; Karon F Cook; Mark P Jensen; Wen-Hung Chen; Seung Choi; Dennis Revicki; David Cella; Nan Rothrock; Francis Keefe; Leigh Callahan; Jin-Shei Lai Journal: Pain Date: 2010-07 Impact factor: 6.961
Authors: K M Kampman; J R Volpicelli; D E McGinnis; A I Alterman; R M Weinrieb; L D'Angelo; L E Epperson Journal: Addict Behav Date: 1998 Jul-Aug Impact factor: 3.913
Authors: H Breivik; P C Borchgrevink; S M Allen; L A Rosseland; L Romundstad; E K Breivik Hals; G Kvarstein; A Stubhaug Journal: Br J Anaesth Date: 2008-05-16 Impact factor: 9.166
Authors: Madhukar H Trivedi; Tracy L Greer; Bruce D Grannemann; Timothy S Church; Eugene Somoza; Steven N Blair; Jose Szapocznik; Mark Stoutenberg; Chad Rethorst; Diane Warden; Kolette M Ring; Robrina Walker; David W Morris; Andrzej S Kosinski; Tiffany Kyle; Bess Marcus; Becca Crowell; Neal Oden; Edward Nunes Journal: Trials Date: 2011-09-19 Impact factor: 2.279
Authors: Manish K Jha; Bruce D Grannemann; Joseph M Trombello; E Will Clark; Sara Levinson Eidelman; Tiffany Lawson; Tracy L Greer; A John Rush; Madhukar H Trivedi Journal: Ann Fam Med Date: 2019-07 Impact factor: 5.166
Authors: Robrina Walker; Thomas F Northrup; John Tillitski; Ira Bernstein; Tracy L Greer; Madhukar H Trivedi Journal: Subst Use Misuse Date: 2019-01-18 Impact factor: 2.164
Authors: Adriane M Dela Cruz; Thomas Carmody; Tracy L Greer; Chad D Rethorst; Diane Warden; Robrina Walker; Madhukar H Trivedi Journal: Am J Addict Date: 2016-03-15
Authors: Chad D Rethorst; Heidi A Hamann; Thomas J Carmody; Kendall J Sharp; Keith E Argenbright; Barbara B Haley; Celette Sugg Skinner; Madhukar H Trivedi Journal: BMC Cancer Date: 2018-07-18 Impact factor: 4.430
Authors: Kristin Martin-Cook; Lucy Palmer; Larry Thornton; A John Rush; Carol A Tamminga; Hicham M Ibrahim Journal: Neuropsychiatr Dis Treat Date: 2021-05-25 Impact factor: 2.570